References: |
1. Stefan N, Fritsche A, Weikert C, Boeing H, Joost HG, Haring HU, Schulze MB. Plasma Fetuin-A
Levels and the Risk of Type 2 Diabetes. Diabetes. 2008 Jul 15;
2. Ebinuma H, Miyazaki O, Yago H, Hara K, Yamauchi T, Kadowaki T. A novel ELISA system for
selective measurement of human adiponectin multimers by using proteases. Clin Chim Acta.
2006 Oct;372 (1-2):47-53
3. Nakano Y, Tajima S, Yoshimi A, Akiyama H, Tsushima M, Tanioka T, Negoro T, Tomita M, Tobe T. A
novel enzyme-linked immunosorbent assay specific for high-molecular-weight adiponectin. J
Lipid Res. 2006 Jul;47 (7):1572-82
4. Berg AH, Combs TP, Scherer PE. ACRP30/adiponectin: an adipokine regulating glucose and
lipid metabolism. Trends Endocrinol Metab. 2002;13:84-89.
5. Iwashima Y, Horio T, Kumada M, Suzuki Y, Kihara S, Rakugi H, Kawano Y, Funahashi T, Ogihara T.
Adiponectin and renal function, and implication as a risk of cardiovascular disease. Am J
Cardiol. 2006 Dec 15;98 (12):1603-8
Page 2 of 7 (VERSION: 2009-10-21)
6. Ahima R, Schraw T, Kos K, McTernan PG, Kusminski CM, Scherer PE, Kumar S, O'Hare JP.
Adiponectin complexes in human cerebrospinal fluid: distinct complex distribution from serum.
Diabetologia. 2007 Mar;50 (3):634-42
7. Wang Y, Lam KS, Xu JY, Lu G, Xu LY, Cooper GJ, Xu A. Adiponectin inhibits cell proliferation by
interacting with several growth factors in an oligomerization-dependent manner. J Biol Chem.
2005 May 6;280 (18):18341-7
8. Klein RL, Garvey WT, Lara-Castro C, Wallace P, Luo N. Adiponectin multimeric complexes and
the metabolic syndrome trait cluster. Diabetes. 2006 Jan;55 (1):249-59
9. Whitehead JP, Richards AA, Prins JB, Stephens T, Charlton HK, Jones A, Macdonald GA.
Adiponectin multimerization is dependent on conserved lysines in the collagenous domain:
evidence for regulation of multimerization by alterations in posttranslational modifications. Mol
Endocrinol. 2006 Jul;20 (7):1673-87
10. Okamoto Y, Kihara S, et al. Adiponectin reduces atherosclerosis in apolipoprotein E-deficient
mice. Circulation. 2002;106:2767-2770.
11. Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, Uchida S, Yamashita S, Noda M, Kita S, Ueki K,
Eto K, Akanuma Y, Froguel P, Foufelle F, Ferre P, Carling D, Kimura S, Nagai R, Kahn BB, Kadowaki
T. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-
activated protein kinase. Nat Med. 2002; 8:1288-1295.
12. Chen H, Montagnani M, Funahashi T, Shimomura I, Quon MJ. Adiponectin stimulates production
of nitric oxide in vascular endothelial cells. J Biol Chem. 2003;278:45021-45026.
13. Grambow SC, Freemark MS, Haqq AM, Muehlbauer M, Newgard CB, Svetkey LP, Purnell JQ.
Altered distribution of adiponectin isoforms in children with Prader-Willi syndrome (PWS):
association with insulin sensitivity and circulating satiety peptide hormones. Clin Endocrinol
(Oxf). 2007 Dec;67 (6):944-51
14. Sinha MK, Songer T, Xiao Q, Sloan JH, Wang J, Ji S, Alborn WE, Davis RA, Swarbrick MM,
Stanhope KL, Wolfe BM, Havel PJ, Schraw T, Konrad RJ, Scherer PE, Mistry JS. Analytical validation
and biological evaluation of a high molecular-weight adiponectin ELISA. Clin Chem. 2007 Dec;53
(12):2144-51
15. Havel PJ, Wolfe BM, Swarbrick MM, Austrheim-Smith IT, Stanhope KL, Van Loan MD, Ali MR.
Circulating concentrations of high-molecular-weight adiponectin are increased following Roux-
en-Y gastric bypass surgery. Diabetologia. 2006 Nov;49 (11):2552-8
16. Komura N, Kihara S, Sonoda M, Kumada M, Fujita K, Hiuge A, Okada T, Nakagawa Y, Tamba S,
Kuroda Y, Hayashi N, Sumitsuji S, Kawamoto T, Matsumoto S, Ouchi N, Arita Y, Okamoto Y,
Shimomura I, Funahashi T, Matsuzawa Y. Clinical significance of high-molecular weight form of
adiponectin in male patients with coronary artery disease. Circ J. 2008 Jan;72 (1):23-8
17. Scherer PE, Pajvani UB, Hawkins M, Rajala MW, Combs TP, Doebber T, Berger JP, Wagner JA, Wu
M, Knopps A, Xiang AH, Utzschneider KM, Kahn SE, Olefsky JM, Buchanan TA. Complex
distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated
improvement in insulin sensitivity. J Biol Chem. 2004 Mar 26;279 (13):12152-62
18. Fukui H, Uemura M, Akahane T, Tsujimoto T, Yamazaki M, Namisaki T, Yanase K, Yoshii J, Kaji K,
Kitade M, Ikenaka Y, Noguchi R, Yoshiji H, Asada K. Crosstalk between high-molecular-weight
adiponectin and T-cadherin during liver fibrosis development in rats. Int J Mol Med. 2007 Nov;20
(5):725-9
19. Hanley AJ, Retnakaran R, Connelly PW, Maguire G, Sermer M, Zinman B. Decreased high-
molecular-weight adiponectin in gestational diabetes: implications for the pathophysiology of
Type 2 diabetes. Diabet Med. 2007 Mar;24 (3):245-52
20. Bernstein LE, Canavan B, Torriani M, Jackson MB, Ahima RS, Grinspoon SK, Lo J. Effects of TNF-
alpha neutralization on adipocytokines and skeletal muscle adiposity in the metabolic syndrome.
Am J Physiol Endocrinol Metab. 2007 Jul;293 (1):E102-9
21. Chen TH, Chen L, Hsieh MS, Chang CP, Chou DT, Tsai SH. Evidence for a protective role for
adiponectin in osteoarthritis. Biochim Biophys Acta. 2006 Aug;1762 (8):711-8
22. Oki K, Koide J, Nakanishi S, Nakashima R, Yamane K. Fenofibrate increases high molecular
weight adiponectin in subjects with hypertriglyceridemia.
Page 3 of 7 (VERSION: 2009-10-21)
Endocr J. 2007 Jun;54 (3):431-5
23. Andersen KK, Frystyk J, Wolthers OD, Heuck C, Flyvbjerg A. Gender differences of oligomers and
total adiponectin during puberty: a cross-sectional study of 859 Danish school children. J Clin
Endocrinol Metab. 2007 May;92 (5):1857-62
24. Waki H, Yamauchi T, Kamon J, Kita S, Ito Y, Hada Y, Uchida S, Tsuchida A, Takekawa S, Kadowaki
T. Generation of globular fragment of adiponectin by leukocyte elastase secreted by monocytic
cell line THP-1. Endocrinology. 2005 Feb;146(2):790-6. Epub 2004 Nov 4.
25. Kasai K, Matsuoka H, Suzuki K, Nishikimi T, Akimoto K, Hattori S, Hattori Y. Globular adiponectin
activates nuclear factor-kappaB and activating protein-1 and enhances angiotensin II-induced
proliferation in cardiac fibroblasts. Diabetes. 2007 Mar;56 (3):804-8
26. Hughes JT, Shen Y, Charlesworth JA, Peake PW. Glycosylation of human adiponectin affects its
conformation and stability. J Mol Endocrinol. 2007 Jul;39 (1):45-52
27. Odden N, Morkrid L. High molecular weight adiponectin dominates in cord blood of newborns
but is unaffected by pre-eclamptic pregnancies. Clin Endocrinol (Oxf). 2007 Dec;67 (6):891-6
28. Brenner DA, Adachi M. High molecular weight adiponectin inhibits proliferation of hepatic
stellate cells via activation of adenosine monophosphate-activated protein kinase. Hepatology.
2008 Feb;47 (2):677-85
29. Buechler C, Weigert J, Sigruener A, Eggenhofer E, Scholmerich J, Neumeier M, Schmitz G,
Langmann T, Piso P, Schaeffler A, Aslanidis C, Schlitt HJ, Weiss TS. High molecular weight
adiponectin reduces apolipoprotein B and E release in human hepatocytes. Biochem Biophys
Res Commun. 2007 Jan 12;352 (2):543-8
30. Seino Y, Hirose H, Saito I, Itoh H. High molecular weight multimer form of adiponectin as a
useful marker to evaluate insulin resistance and metabolic syndrome in Japanese men.
Metabolism. 2007 Nov;56 (11):1493-9
31. Araki S, Dobashi K, Kubo K, Asayama K, Shirahata A. High molecular weight, rather than total,
adiponectin levels better reflect metabolic abnormalities associated with childhood obesity. J
Clin Endocrinol Metab. 2006 Dec;91 (12):5113-6
32. Dugi KA, Bierhaus A, Nawroth PP, Allolio B, Hamann A, Lepper PM, Bluemm A, Humpert PM, von
Eynatten M. High-molecular weight adiponectin is independently associated with the extent of
coronary artery disease in men. Atherosclerosis. 2008 Jul;199 (1):123-8
33. Salani B, Briatore L, Adami GF, Andraghetti G, Maggi D, Cordera R. High-molecular weight
adiponectin isoforms increase after biliopancreatic diversion in obese subjects. Obesity (Silver
Spring). 2006 Sep;14 (9):1511-4
34. Wang Y, Xu A, Knight C, Xu LY, Cooper GJ. Hydroxylation and glycosylation of the four
conserved lysine residues in the collagenous domain of adiponectin. Potential role in the
modulation of its insulin-sensitizing activity. J Biol Chem. 2002; 277:19521-19529.
35. Wang Y, Xu A, Knight C, Xu LY, Cooper GJ. Hydroxylation and glycosylation of the four
conserved lysine residues in the collagenous domain of adiponectin. Potential role in the
modulation of its insulin-sensitizing activity. J Biol Chem. 2002; 277:19521-19529.
36. Torigoe M, Matsui H, Ogawa Y, Murakami H, Murakami R, Cheng XW, Numaguchi Y, Murohara T,
Okumura K. Impact of the high-molecular-weight form of adiponectin on endothelial function in
healthy young men. Clin Endocrinol (Oxf). 2007 Aug;67 (2):276-81
37. Waki H, Yamauchi T, Kamon J, Ito Y, Uchida S, Kita S, Hara K, Hada Y, Vasseur F, Froguel P,
Kimura S, Nagai R, Kadowaki T. Impaired multimerization of human adiponectin mutants
associated with diabetes. Molecular structure and multimer formation of adiponectin. J Biol
Chem. 2003 Oct 10;278 (41):40352-63
38. Schober F, Neumeier M, Weigert J, Wurm S, Wanninger J, Schaffler A, Dada A, Liebisch G, Schmitz
G, Aslanidis C, Buechler C. Low molecular weight adiponectin negatively correlates with the waist
circumference and monocytic IL-6 release. Biochem Biophys Res Commun. 2007 Oct 5;361 (4):968-
73
39. Hamilton JK, Connelly PW, Sermer M, Maguire G, Zinman B, Hanley AJ, Retnakaran R, Ong GK.
Maternal serum adiponectin and infant birthweight: the role of adiponectin isoform distribution.
Clin Endocrinol (Oxf). 2007 Jul;67 (1):108-14
Page 4 of 7 (VERSION: 2009-10-21)
40. Hara K, Horikoshi M, Yamauchi T, Yago H, Miyazaki O, Ebinuma H, Imai Y, Nagai R, Kadowaki T.
Measurement of the high-molecular weight form of adiponectin in plasma is useful for the
prediction of insulin resistance and metabolic syndrome. Diabetes Care. 2006 Jun;29 (6):1357-62
41. Tonelli J, Li W, Kishore P, Pajvani UB, Kwon E, Weaver C, Scherer PE, Hawkins M. Mechanisms of
early insulin-sensitizing effects of thiazolidinediones in type 2 diabetes. Diabetes. 2004 Jun;53
(6):1621-9
42. Hemi R, Yissachar E, Modan-Moses D, Pariente C, Kanety H, Stein D, Yaroslavsky A, Ram A, Faigin
M, Loewenthal R. Modulation of adiponectin and leptin during refeeding of female anorexia
nervosa patients. J Clin Endocrinol Metab. 2007 May;92 (5):1843-7
43. Macdonald GA, Prins JB, Hickman IJ, Wang AY, Jones AL, Newell F, Richards AA, Mowry BJ,
Whitehead JP. Olanzapine treatment is associated with reduced high molecular weight
adiponectin in serum: a potential mechanism for olanzapine-induced insulin resistance in
patients with schizophrenia. J Clin Psychopharmacol. 2006 Jun;26 (3):232-7
44. Semple RK, Halberg NH, Burling K, Soos MA, Schraw T, Luan J, Cochran EK, Dunger DB, Wareham
NJ, Scherer PE, Gorden P, O'Rahilly S. Paradoxical elevation of high-molecular weight
adiponectin in acquired extreme insulin resistance due to insulin receptor antibodies. Diabetes.
2007 Jun;56 (6):1712-7
45. Bodles AM, Banga A, Rasouli N, Ono F, Kern PA, Owens RJ. Pioglitazone increases secretion of
high-molecular-weight adiponectin from adipocytes. Am J Physiol Endocrinol Metab. 2006
Nov;291 (5):E1100-5
46. Scherer PE, Hawkins M, Halberg N, Wang ZV, Schraw T. Plasma adiponectin complexes have
distinct biochemical characteristics. Endocrinology. 2008 May;149 (5):2270-82
47. Schraw T, Wang ZV, Halberg N, Hawkins M, Scherer PE. Plasma adiponectin complexes have
distinct biochemical characteristics. Endocrinology. 2008 May;149 (5):2270-82
48. Wang Y, Lam KS, Chan L, Chan KW, Lam JB, Lam MC, Hoo RC, Mak WW, Cooper GJ, Xu A. Post-
translational modifications of the four conserved lysine residues within the collagenous domain
of adiponectin are required for the formation of its high molecular weight oligomeric complex. J
Biol Chem. 2006 Jun 16;281 (24):16391-400
49. Westphal S, Luley C. Preferential increase in high-molecular weight adiponectin after niacin.
Atherosclerosis. 2008 May;198 (1):179-83
50. Tajima N, Nishimura R, Morimoto A, Matsudaira T, Miyashita Y, Sano H, Shirasawa T, Takahashi E.
Ratio of high-, medium-, and low-molecular weight serum adiponectin to the total adiponectin
value in children. J Pediatr. 2007 Nov;151 (5):545-7, 547.e1-2
51. Matsuda M, Shimomura I, et al. Role of adiponectin in preventing vascular stenosis. The
missing link of adipo-vascular axis. J Biol Chem. 2002;277:37487-37491.
52. Basu R, Pajvani UB, Rizza RA, Scherer PE. Selective downregulation of the high molecular
weight form of adiponectin in hyperinsulinemia and in type 2 diabetes: differential regulation
from nondiabetic subjects. Diabetes. 2007 Aug;56 (8):2174-7
53. Takemura Y, Osuga Y, Koga K, Tajima T, Hirota Y, Hirata T, Morimoto C, Harada M, Yano T,
Taketani Y. Selective increase in high molecular weight adiponectin concentration in serum of
women with preeclampsia. J Reprod Immunol. 2007 Feb;73 (1):60-5
54. Kobayashi H, Ouchi N, Kihara S, Walsh K, Kumada M, Abe Y, Funahashi T, Matsuzawa Y, Ferre P.
Selective Suppression of Endothelial Cell Apoptosis by the High Molecular Weight.
55. Kobayashi H, Ouchi N, Kihara S, Walsh K, Kumada M, Abe Y, et al. Selective suppression of
endothelial cell apoptosis by the high molecular weight form of adiponectin. Circulation research.
2004 Mar 5;94(4):e27-31.
56. Kobayashi H, Ouchi N, Kihara S, Walsh K, Kumada M, Abe Y, Funahashi T, Matsuzawa Y. Selective
suppression of endothelial cell apoptosis by the high molecular weight form of adiponectin.
Circ Res. 2004 Mar 5;94 (4):e27-31
57. Hui CK, Zhang HY, Lee NP, Chan W, Yueng YH, Leung KW, Lu L, Leung N, Lo CM, Fan ST, Luk JM,
Xu A, Lam KS, Kwong YL, Lau GK. Serum adiponectin is increased in advancing liver fibrosis and
declines with reduction in fibrosis in chronic hepatitis B. J Hepatol. 2007 Aug;47 (2):191-202
Page 5 of 7 (VERSION: 2009-10-21)
58. Kumar S, Scherer PE, McTernan PG, Barnett AH, Hanif W, Trujillo ME, Fisher FF. Serum high
molecular weight complex of adiponectin correlates better with glucose tolerance than total
serum adiponectin in Indo-Asian males. Diabetologia. 2005 Jun;48 (6):1084-7
59. Nakatani H, Hirose H, Yamamoto Y, Saito I, Itoh H. Significance of leptin and high-molecular
weight adiponectin in the general population of Japanese male adolescents. Metabolism. 2008
Feb;57 (2):157-62
60. Pajvani UB, Du X, Combs TP, Berg AH, Rajala MW, Schulthess T, Engel J, Brownlee M, Scherer PE.
Structure-function studies of the adipocyte-secreted hormone Acrp30/adiponectin. Implications
fpr metabolic regulation and bioactivity. J Biol Chem. 2003; 278:9073-85.
61. Pajvani UB, Du X, Combs TP, Berg AH, Rajala MW, Schulthess T, Engel J, Brownlee M, Scherer PE.
Structure-function studies of the adipocyte-secreted hormone Acrp30/adiponectin. Implications
fpr metabolic regulation and bioactivity. J Biol Chem. 2003; 278:9073-85.
62. Hug C, Wang J, Ahmad NS, Bogan JS, Tsao TS, Lodish HF. T-cadherin is a receptor for
hexameric and high-molecular-weight forms of Acrp30/adiponectin. Proc Natl Acad Sci U S A.
2004 Jul 13;101 (28):10308-13
63. Xu A, Chan KW, Hoo RL, Wang Y, Tan KC, Zhang J, Chen B, Lam MC, Tse C, Cooper GJ, Lam KS.
Testosterone selectively reduces the high molecular weight form of adiponectin by inhibiting its
secretion from adipocytes. J Biol Chem. 2005 May 6;280 (18):18073-80
64. Berg AH, Combs TP, Du X, Brownlee M, Scherer PE. The adipocyte-secreted protein Acrp30
enhances hepatic insulin action. Nat Med. 2001; 7:947-953.
65. Beulens JW, van Loon LJ, Kok FJ, Pelsers M, Bobbert T, Spranger J, Helander A, Hendriks HF. The
effect of moderate alcohol consumption on adiponectin oligomers and muscle oxidative
capacity: a human intervention study. Diabetologia. 2007 Jul;50 (7):1388-92
66. Xu A, Wang Y, Keshaw H, Xu LY, Lam KS, Cooper GJ. The fat-derived hormone adiponectin
alleviates alcoholic and nonalcoholic fatty liver diseases in mice. J Clin Invest. 2003; 112:91-100.
67. Yamauchi T, Kamon J, et al. The fat-derived hormone adiponectin reverses insulin resistance
associated with both lipoatrophy and obesity. Nat Med. 2001;7:941-946.
68. Kriketos AD, Peake PW, Charlesworth JA, Campbell LV, Shen Y. The metabolism of isoforms of
human adiponectin: studies in human subjects and in experimental animals. Eur J Endocrinol.
2005 Sep;153 (3):409-17
69. Tsao TS, Wert D, Wilson-Kubalek EM, Suzuki S, Lee DH. The oligomeric structure of high
molecular weight adiponectin. FEBS Lett. 2007 Mar 6;581 (5):809-14
70. Shulman GI, Rothman DL, Petersen KF, Dufour S, Savage DB, Bilz S, Solomon G, Yonemitsu S,
Cline GW, Befroy D, Zemany L, Kahn BB, Papademetris X. The role of skeletal muscle insulin
resistance in the pathogenesis of the metabolic syndrome. Proc Natl Acad Sci U S A. 2007 Jul
31;104 (31):12587-94
71. Lodish HF, Hug C. The role of the adipocyte hormone adiponectin in cardiovascular disease.
Curr Opin Pharmacol. 2005 Apr;5 (2):129-34
72. Glintborg D, Frystyk J, Hojlund K, Andersen KK, Henriksen JE, Hermann AP, Hagen C, Flyvbjerg A,
Andersen M. Total and high molecular weight (HMW) adiponectin levels and measures of glucose
and lipid metabolism following pioglitazone treatment in a randomized placebo-controlled study
in polycystic ovary syndrome. Clin Endocrinol (Oxf). 2008 Feb;68 (2):165-74
73. Horie M, Yamamoto T, Fujii M, Ishikawa C, Sakai H, Tanaka T, Tsutamoto T. Total and high
molecular weight adiponectin, haemodynamics, and mortality in patients with chronic heart
failure. Eur Heart J. 2007 Jul;28 (14):1723-30
74. Sweeney G, Tungtrongchitr R, Shaw C, Liu Y, Retnakaran R, Hanley A. Total and high molecular
weight but not trimeric or hexameric forms of adiponectin correlate with markers of the
metabolic syndrome and liver injury in Thai subjects. J Clin Endocrinol Metab. 2007 Nov;92
(11):4313-8
75. Bluher M, Mantzoros CS, Williams CJ, Kralisch S, Fasshauer M, Kelesidis T, Kratzsch J, Brennan
AM. Total and high-molecular weight adiponectin in relation to metabolic variables at baseline
and in response to an exercise treatment program: comparative evaluation of three assays.
Diabetes Care. 2007 Feb;30 (2):280-5
Page 6 of 7 (VERSION: 2009-10-21)
76. Peake PW, Shen YY, Charlesworth JA, Kelly JJ, Loi KW. Up-regulation of adiponectin, its
isoforms and receptors in end-stage kidney disease. Nephrol Dial Transplant. 2007 Jan;22 (1):171-
8 |